Trial Profile
Safety and efficacy of autologous, intracoronary stem cell injections in total coronary artery occlusions
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 25 Mar 2022
Price :
$35
*
At a glance
- Drugs ACY 001 (Primary)
- Indications Coronary artery disease
- Focus Adverse reactions; Therapeutic Use
- Acronyms SEACOAST
- 09 Mar 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 19 Oct 2006 New trial record.